Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 48 for “"Ube3A"”.

  1. UBE3A and Angelman syndrome: a substrate perspective

    … loss of function of a single ubiquitin ligase, UBE3A, was sufficient to give rise to AS phenotypes. A prevailing hypothesis in the field is that levels of proteins normally marked for degradation via the 26S proteasome by UBE3A are elevated upon UBE3A’s loss of function. These elevated substrate …

    jhu Repository record for UBE3A and Angelman syndrome: a substrate perspective (opens in a new tab)

  2. Analysis of Genomic Imprinting of UBE3A in Neurons

    … loss-of-expression of the maternally inherited UBE3A allele; Dup15q syndrome is attributed to maternally inherited copy number gains of UBE3A; and, paternally inherited deletions of the SNORD116 cluster cause PWS. The UBE3A gene is imprinted in the brain with maternal-specific expression and …

    tamu Repository record for Analysis of Genomic Imprinting of UBE3A in Neurons (opens in a new tab)

  3. Understanding the Imprinting Mechanism of UBE3A for Therapeutic Intervention

    … inherited ubiquitin E3A protein ligase gene (UBE3A). Prader-Willi syndrome is caused by loss-of-function of paternally inherited SNORD116 snoRNAs (small nucleolar RNAs), which are expressed as part of a long polycistronic transcriptional unit (PTU) comprised of SNURF-SNRPN, additional orphan …

    tamu Repository record for Understanding the Imprinting Mechanism of UBE3A for Therapeutic Intervention (opens in a new tab)

  4. The autism protein UBE3A/E6AP regulates remodeling of neuronal dendritic arborization

    … heritability. Ubiquitin protein ligase E3A (UBE3A) is a gene located on human chromosome 15q11-13, a region that has been the focus of genetic studies of susceptibility to ASD AND Angelman syndrome. An increased UBE3A gene dosage and thus an elevated amount of E6AP, the protein product of …

    bu Repository record for The autism protein UBE3A/E6AP regulates remodeling of neuronal dendritic arborization (opens in a new tab)

  5. Ube3a Role in Synaptic Plasticity and Neurodevelopmental Disorders.The Lessons from Angelman Syndrome.

    … of AS cases arise from deletions or mutations of UBE3A gene located on the chromosome 15q11-13. UBE3A codes for E3-ubiquitin ligase that target specific proteins for degradation. To date, a wide variety of Ube3a substrates has been identified. The accumulation of Ube3a-dependent proteins and their …

    usf Repository record for Ube3a Role in Synaptic Plasticity and Neurodevelopmental Disorders.The Lessons from Angelman Syndrome. (opens in a new tab)

  6. Activity-dependent Regulation of Extracellular UBE3A in a Novel Angelman Syndrome Rat Model

    … loss of function of the maternal allele of UBE3A, encoding for an E3 ubiquitin ligase, leads to the manifestation of AS. There are currently no cures for AS and few therapeutic options to abate symptoms. Although much investigation is required, research using the null mutation AS mouse model …

    usf Repository record for Activity-dependent Regulation of Extracellular UBE3A in a Novel Angelman Syndrome Rat Model (opens in a new tab)

  7. Investigating the role of autism gene Ube3a in the transcriptional regulation in neurons

    UBE3A is a protein with dual functions as an E3 ubiquitin ligase and as a Steroid Hormone Receptor (SHR) transcriptional coactivator. It is expressed ubiquitously in tissues and has significant importance in neurons, where it is expressed exclusively from the maternal allele. Thus, while UBE3A has …

    bu Repository record for Investigating the role of autism gene Ube3a in the transcriptional regulation in neurons (opens in a new tab)

  8. Astrocytic roles in regulating dendritic spine maturation in UBe3A-dependent autism spectrum disorder

    … with many genes linked to their etiology. UBE3A has been identified as a top gene candidate associated with ASD, and overexpression of UBE3A via copy-number variation confers hallmark ASD behaviors in humans and transgenic mice. Our previous work revealed that synapse formation was …

    bu Repository record for Astrocytic roles in regulating dendritic spine maturation in UBe3A-dependent autism spectrum disorder (opens in a new tab)

  9. Identification and Characterization of UBE3A Gain of Function Variants as a Driver of Neurodevelopmental Disease

    UBE3A is a HECT (homologous to E6AP-Terminus) domain E3 ubiquitin ligase that targets substrate proteins for polyubiquitination and subsequent degradation through the ubiquitin-proteasome pathway. The UBE3A gene is of unique interest for its gene dosage-dependent effect in the developing brain: …

    wustl Repository record for Identification and Characterization of UBE3A Gain of Function Variants as a Driver of Neurodevelopmental Disease (opens in a new tab)

  10. IDENTIFICATION OF SUBSTRATES OF THE E3 UBIQUITIN LIGASE, UBE3A, AND UNDERSTANDING THEIR ROLES IN NEURODEVELOPMENTAL DISORDERS

    UBE3A is a HECT E3 ubiquitin ligase that is biallelically expressed in most tissues, but paternally imprinted in the brain and plays critical roles in neurodevelopment. Maternal UBE3A is mutated in Angelman Syndrome (AS), a neurodevelopmental disorder characterized by severe intellectual …

    jhu Repository record for IDENTIFICATION OF SUBSTRATES OF THE E3 UBIQUITIN LIGASE, UBE3A, AND UNDERSTANDING THEIR ROLES IN NEURODEVELOPMENTAL DISORDERS (opens in a new tab)

  11. The influence of UBE3A, NEDD4L, and ARFGEF2 on the progression of Angelman syndrome and sickle cell anemia

    This project investigates the impact of UBE3A, NEDD4L, and ARFGEF2 on disorder and disease in humans. UBE3A is a member of the homologous to E6AP COOH-terminus (HECT) E3 ubiquitin ligase family and is parentally imprinted in certain cell types. Mutation of the gene causes Angelman syndrome (AS), …

    bu Repository record for The influence of UBE3A, NEDD4L, and ARFGEF2 on the progression of Angelman syndrome and sickle cell anemia (opens in a new tab)

  12. Alteration of Golgi Apparatus Ion Homeostasis in Cellular and Mouse Models of Angelman Syndrome

    <p>Ube3a is a HECT domain E3 ubiquitin ligase originally recognized for its role in degrading p53 in the presence of the human papilloma virus protein E6. Loss of maternal Ube3a expression causes Angelman syndrome, a severe neurodevelopmental disorder characterized by mental retardation, ataxia, …

    duke Repository record for Alteration of Golgi Apparatus Ion Homeostasis in Cellular and Mouse Models of Angelman Syndrome (opens in a new tab)

  13. Investigation of the molecular mechanisms in UBE3A-dependent autism spectrum disorder: insights into sexual dimorphism and synaptic defects

    … communication, and behavioral challenges. UBE3A is one of the most common ASD genes, and transgenic mice with UBE3A overexpression exhibit typical autistic behaviors. ASDs display a remarkable sex difference with a 4:1 male to female prevalence ratio; however, the underlying mechanism …

    bu Repository record for Investigation of the molecular mechanisms in UBE3A-dependent autism spectrum disorder: insights into sexual dimorphism and synaptic defects (opens in a new tab)

  14. Efficacy of Increased Ube3a Protein Levels in the Brain in Rescuing the Phenotype of an Angelman Syndrome Mouse

    … The gene responsible for AS was discovered to be UBE3A and encodes an E6-AP ubiquitin ligase. A unique feature of this gene is that it undergoes maternal imprinting in a neuron-specific manner. In the majority of AS cases, there is a mutation or deletion in the maternally inherited UBE3A gene, …

    usf Repository record for Efficacy of Increased Ube3a Protein Levels in the Brain in Rescuing the Phenotype of an Angelman Syndrome Mouse (opens in a new tab)

  15. Investigations into the Improvement of Angelman Syndrome Therapeutics

    … of the function of the ubiquitin ligase UBE3A gene. Patients experience an early life onset of symptoms which include pronounced intellectual disability, drastic speech impairmentor inability to speak, severe movement disorders, seizures, aggression, disruptive sleep impairment, and …

    usf Repository record for Investigations into the Improvement of Angelman Syndrome Therapeutics (opens in a new tab)

  16. Role of CBLN1’S RE-1 transcriptional regulatory sequences in gene repression

    … synergize with transcriptional co-regulator Ube3a to repress Cbln1 expression, which ultimately manifests as ASD associated behavioral discrepancies. (Krishnan et al., 2017) Seizures increase the expression of REST and the Cbln1 gene contains an intronic RE-1 binding site previously shown to …

    bu Repository record for Role of CBLN1’S RE-1 transcriptional regulatory sequences in gene repression (opens in a new tab)

  17. Μοριακή μελέτη ασθενών με σύνδρομο Angelman: συσχέτιση φαινότυπου - γονότυπου

    … phenotype caused by deficiency of maternal UBE3A gene expression on the imprinted Prader Willi/ Angelman syndrome critical region which results from chromosomal deletions, uniparental disomy and imprinting defects of the 15q11-q13 region in 70- 80% of patients. Loss of function mutations in …

    greece Repository record for Μοριακή μελέτη ασθενών με σύνδρομο Angelman: συσχέτιση φαινότυπου - γονότυπου (opens in a new tab)

  18. A Translational Pig Model of Angelman Syndrome: Establishing a Foundation for Preclinical Research and Therapeutic Development

    … of the imprinted ubiquitin-protein ligase E3A (UBE3A) gene, and no approved therapies currently exist. Although numerous rodent models have been developed over the past three decades, none fully recapitulate the clinical features of the condition, and rodents remain limited as preclinical …

    tamu Repository record for A Translational Pig Model of Angelman Syndrome: Establishing a Foundation for Preclinical Research and Therapeutic Development (opens in a new tab) Embargoed until 2027-08-01

  19. A Translational Pig Model of Angelman Syndrome: Establishing a Foundation for Preclinical Research and Therapeutic Development

    … of the imprinted ubiquitin-protein ligase E3A (UBE3A) gene, and no approved therapies currently exist. Although numerous rodent models have been developed over the past three decades, none fully recapitulate the clinical features of the condition, and rodents remain limited as preclinical …

    tamu Repository record for A Translational Pig Model of Angelman Syndrome: Establishing a Foundation for Preclinical Research and Therapeutic Development (opens in a new tab) Embargoed until 2027-08-01

  20. A Translational Pig Model of Angelman Syndrome: Establishing a Foundation for Preclinical Research and Therapeutic Development

    … of the imprinted ubiquitin-protein ligase E3A (UBE3A) gene, and no approved therapies currently exist. Although numerous rodent models have been developed over the past three decades, none fully recapitulate the clinical features of the condition, and rodents remain limited as preclinical …

    tamu Repository record for A Translational Pig Model of Angelman Syndrome: Establishing a Foundation for Preclinical Research and Therapeutic Development (opens in a new tab) Embargoed until 2027-08-01

Page 1 of 3